Sulfonylurea therapy is associated with increased NT-proBNP levels in the treatment of type 2 diabetes

Levels of NT-proBNP are associated with increasing sulfonylurea dosage, age, blood pressure, and creatinine levels. There is unlikely to be clinically significant differences in NT-proBNP levels between patients with type 2 diabetes and a normal population.